Transcriptional Therapeutics Trademark Details

Transcriptional Therapeutics was registered on Tuesday, April 7, 2009 and is currently owned by Precigen, Inc. under the registration number 3604574 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, November 13, 2015, according to the United State Patent & Trademark Office
Word Mark Transcriptional Therapeutics
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Precigen, Inc. of Germantown, MD

View all trademarks for Precigen, Inc.
Other Trademarks for Precigen, Inc.
Serial Number 77123334
Registration Number 3604574
Status Date Friday, November 13, 2015
Filing Date Friday, November 13, 2015
Registration Date Tuesday, April 7, 2009
Attorney David L. May,

Correspondent

David L. May, Esq.
NIXON PEABODY LLP
401 9th Street, N.W.
Suite 900
Washington DC 20004

Case File Statements

Disclaimer with Predetermined Text "Therapeutics"
Goods & Services Development of new technology for others in the field of genetics, therapeutics, and biotechnology

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, November 13, 2015
First Use Anywhere Tuesday, May 1, 2007
First Use In Commerce Tuesday, May 1, 2007
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.